Drug Shortage Report for MINT-CARBAMAZEPINE
| Report ID | 235587 |
| Drug Identification Number | 02541238 |
| Brand name | MINT-CARBAMAZEPINE |
| Common or Proper name | Carbamazepine |
| Company Name | MINT PHARMACEUTICALS INC |
| Market Status | MARKETED |
| Active Ingredient(s) | CARBAMAZEPINE |
| Strength(s) | 200MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 100 count bottle |
| ATC code | N03AF |
| ATC description | ANTIEPILEPTICS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2024-07-04 |
| Estimated end date | 2024-09-30 |
| Actual end date | 2024-10-07 |
| Shortage status | Resolved |
| Updated date | 2024-10-08 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 6575 DAVAND DRIVE MISSISSAUGA, ONTARIO CANADA L5T 2M3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2024-10-08 | French | Compare |
| v3 | 2024-10-08 | English | Compare |
| v2 | 2024-08-20 | French | Compare |
| v1 | 2024-08-20 | English | Compare |
Showing 1 to 4 of 4